{"id":4724,"date":"2017-01-03T09:10:16","date_gmt":"2017-01-03T12:10:16","guid":{"rendered":"https:\/\/prodoctor.net\/blog\/?p=4724"},"modified":"2021-06-17T15:14:10","modified_gmt":"2021-06-17T18:14:10","slug":"hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento","status":"publish","type":"post","link":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/","title":{"rendered":"Hemofilia A e Esclerose M\u00faltipla ganham novo tratamento"},"content":{"rendered":"<h4>Hemofilia A<\/h4>\n<p>A Anvisa publicou nesta segunda-feira, 2 de janeiro, <strong>o registro do medicamentos Nuwiq<\/strong> que tem como subst\u00e2ncia ativa o fator de coagula\u00e7\u00e3o VIII recombinante humano (alfasimoctocogue). O medicamento, registrado como produto biol\u00f3gico novo, <strong>substitui o fator VIII no corpo humano<\/strong> e \u00e9 utilizado para o <strong>tratamento e preven\u00e7\u00e3o<\/strong> de hemorragias em pacientes com hemofilia A.<\/p>\n<p>O fator VIII est\u00e1 presente no sangue e <strong>\u00e9 necess\u00e1rio para formar co\u00e1gulos<\/strong> e estancar sangramentos de forma natural no organismo. Em pessoas com hemofilia A, <strong>a aus\u00eancia desta subst\u00e2ncia<\/strong> faz com que o doente possa ter sangramentos nas articula\u00e7\u00f5es e mesmo intracranianos.<\/p>\n<p>O <strong>Nuwiq<\/strong> (alfasimoctocogue) pode ser utilizado em <strong>todas as faixas et\u00e1rias<\/strong> e foi aprovado com a indica\u00e7\u00e3o para \u201c<strong>o tratamento e profilaxia de sangramentos<\/strong> em pacientes com hemofilia A (defici\u00eancia cong\u00eanita do fator VIII de coagula\u00e7\u00e3o)\u201d. Apesar de existirem outras substitutos ao fator VIII no mercado, o Nuwiq <strong>foi considerado novo por ter um menor potencial de provocar imunogenicidade<\/strong>.<\/p>\n<h4>Esclerose M\u00faltipla<\/h4>\n<p>O produto biol\u00f3gico novo <strong>Plegridy\u00ae<\/strong> foi registrado e aprovado pela Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa). Ele \u00e9 usado no <strong>tratamento de esclerose m\u00faltipla<\/strong> recorrente-remitente (EMRR) em pacientes adultos. O princ\u00edpio ativo do medicamento Plegridy\u00ae \u00e9 a betapeginterferona 1\u00aa, <strong>subst\u00e2ncia que pode impedir<\/strong> que o sistema de defesa do organismo<strong> danifique o c\u00e9rebro e a medula espinhal<\/strong>.<\/p>\n<p>A betapeginterferona 1\u00aa \u00e9 uma forma modificada de longa dura\u00e7\u00e3o da interferona, <strong>subst\u00e2ncia natural<\/strong> produzida pelo corpo respons\u00e1vel por <strong>auxiliar na prote\u00e7\u00e3o contra infec\u00e7\u00f5es e doen\u00e7as<\/strong>. Embora <strong>n\u00e3o cure a doen\u00e7a<\/strong>, o tratamento com Plegridy\u00ae <strong>pode retardar os efeitos incapacitantes<\/strong> da esclerose m\u00faltipla, al\u00e9m de <strong>auxiliar na redu\u00e7\u00e3o de surtos<\/strong>.<\/p>\n<p>Fonte: Anvisa<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hemofilia A A Anvisa publicou nesta segunda-feira, 2 de janeiro, o registro do medicamentos Nuwiq que tem como subst\u00e2ncia&#8230;<\/p>\n","protected":false},"author":3,"featured_media":19814,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[415],"tags":[],"class_list":["post-4724","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicamentos-e-farmacia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hemofilia A e Esclerose M\u00faltipla ganham novo tratamento<\/title>\n<meta name=\"description\" content=\"A Anvisa publicou o registro dos medicamentos Nuwiq para o tratamento da Hemofilia A e Plegridy\u00ae para o tratamento da Esclerose M\u00faltipla.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hemofilia A e Esclerose M\u00faltipla ganham novo tratamento\" \/>\n<meta property=\"og:description\" content=\"A Anvisa publicou o registro dos medicamentos Nuwiq para o tratamento da Hemofilia A e Plegridy\u00ae para o tratamento da Esclerose M\u00faltipla.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog ProDoctor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/prodoctorsoftware\" \/>\n<meta property=\"article:published_time\" content=\"2017-01-03T12:10:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-17T18:14:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/medicamentos-aprovados.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"770\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Simara Laura Salgado\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@prodoctorsoft\" \/>\n<meta name=\"twitter:site\" content=\"@prodoctorsoft\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simara Laura Salgado\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/\"},\"author\":{\"name\":\"Simara Laura Salgado\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158\"},\"headline\":\"Hemofilia A e Esclerose M\u00faltipla ganham novo tratamento\",\"datePublished\":\"2017-01-03T12:10:16+00:00\",\"dateModified\":\"2021-06-17T18:14:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/\"},\"wordCount\":305,\"publisher\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/medicamentos-aprovados.jpg\",\"articleSection\":[\"Medicamentos e Farm\u00e1cia\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/\",\"url\":\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/\",\"name\":\"Hemofilia A e Esclerose M\u00faltipla ganham novo tratamento\",\"isPartOf\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/medicamentos-aprovados.jpg\",\"datePublished\":\"2017-01-03T12:10:16+00:00\",\"dateModified\":\"2021-06-17T18:14:10+00:00\",\"description\":\"A Anvisa publicou o registro dos medicamentos Nuwiq para o tratamento da Hemofilia A e Plegridy\u00ae para o tratamento da Esclerose M\u00faltipla.\",\"breadcrumb\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#primaryimage\",\"url\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/medicamentos-aprovados.jpg\",\"contentUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/medicamentos-aprovados.jpg\",\"width\":770,\"height\":400,\"caption\":\"medicamentos aprovados\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/prodoctor.net\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hemofilia A e Esclerose M\u00faltipla ganham novo tratamento\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#website\",\"url\":\"https:\/\/prodoctor.net\/blog\/\",\"name\":\"Blog ProDoctor\",\"description\":\"Tudo sobre o mundo da Sa\u00fade\",\"publisher\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/prodoctor.net\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\",\"name\":\"ProDoctor Software S\/A\",\"url\":\"https:\/\/prodoctor.net\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png\",\"contentUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png\",\"width\":2014,\"height\":485,\"caption\":\"ProDoctor Software S\/A\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/prodoctorsoftware\",\"https:\/\/x.com\/prodoctorsoft\",\"https:\/\/www.instagram.com\/prodoctorsoftware\/\",\"https:\/\/www.linkedin.com\/company\/prodoctor-software-ltda\",\"https:\/\/www.youtube.com\/channel\/UCIWuDLsVtIpX-PEqQn1pNlw\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158\",\"name\":\"Simara Laura Salgado\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g\",\"caption\":\"Simara Laura Salgado\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hemofilia A e Esclerose M\u00faltipla ganham novo tratamento","description":"A Anvisa publicou o registro dos medicamentos Nuwiq para o tratamento da Hemofilia A e Plegridy\u00ae para o tratamento da Esclerose M\u00faltipla.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/","og_locale":"pt_BR","og_type":"article","og_title":"Hemofilia A e Esclerose M\u00faltipla ganham novo tratamento","og_description":"A Anvisa publicou o registro dos medicamentos Nuwiq para o tratamento da Hemofilia A e Plegridy\u00ae para o tratamento da Esclerose M\u00faltipla.","og_url":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/","og_site_name":"Blog ProDoctor","article_publisher":"https:\/\/www.facebook.com\/prodoctorsoftware","article_published_time":"2017-01-03T12:10:16+00:00","article_modified_time":"2021-06-17T18:14:10+00:00","og_image":[{"width":770,"height":400,"url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/medicamentos-aprovados.jpg","type":"image\/jpeg"}],"author":"Simara Laura Salgado","twitter_card":"summary_large_image","twitter_creator":"@prodoctorsoft","twitter_site":"@prodoctorsoft","twitter_misc":{"Escrito por":"Simara Laura Salgado","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#article","isPartOf":{"@id":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/"},"author":{"name":"Simara Laura Salgado","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158"},"headline":"Hemofilia A e Esclerose M\u00faltipla ganham novo tratamento","datePublished":"2017-01-03T12:10:16+00:00","dateModified":"2021-06-17T18:14:10+00:00","mainEntityOfPage":{"@id":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/"},"wordCount":305,"publisher":{"@id":"https:\/\/prodoctor.net\/blog\/#organization"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#primaryimage"},"thumbnailUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/medicamentos-aprovados.jpg","articleSection":["Medicamentos e Farm\u00e1cia"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/","url":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/","name":"Hemofilia A e Esclerose M\u00faltipla ganham novo tratamento","isPartOf":{"@id":"https:\/\/prodoctor.net\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#primaryimage"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#primaryimage"},"thumbnailUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/medicamentos-aprovados.jpg","datePublished":"2017-01-03T12:10:16+00:00","dateModified":"2021-06-17T18:14:10+00:00","description":"A Anvisa publicou o registro dos medicamentos Nuwiq para o tratamento da Hemofilia A e Plegridy\u00ae para o tratamento da Esclerose M\u00faltipla.","breadcrumb":{"@id":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#primaryimage","url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/medicamentos-aprovados.jpg","contentUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/medicamentos-aprovados.jpg","width":770,"height":400,"caption":"medicamentos aprovados"},{"@type":"BreadcrumbList","@id":"https:\/\/prodoctor.net\/blog\/hemofilia-a-e-esclerose-multipla-ganham-novo-tratamento\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/prodoctor.net\/blog\/"},{"@type":"ListItem","position":2,"name":"Hemofilia A e Esclerose M\u00faltipla ganham novo tratamento"}]},{"@type":"WebSite","@id":"https:\/\/prodoctor.net\/blog\/#website","url":"https:\/\/prodoctor.net\/blog\/","name":"Blog ProDoctor","description":"Tudo sobre o mundo da Sa\u00fade","publisher":{"@id":"https:\/\/prodoctor.net\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prodoctor.net\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/prodoctor.net\/blog\/#organization","name":"ProDoctor Software S\/A","url":"https:\/\/prodoctor.net\/blog\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png","contentUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png","width":2014,"height":485,"caption":"ProDoctor Software S\/A"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/prodoctorsoftware","https:\/\/x.com\/prodoctorsoft","https:\/\/www.instagram.com\/prodoctorsoftware\/","https:\/\/www.linkedin.com\/company\/prodoctor-software-ltda","https:\/\/www.youtube.com\/channel\/UCIWuDLsVtIpX-PEqQn1pNlw"]},{"@type":"Person","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158","name":"Simara Laura Salgado","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g","caption":"Simara Laura Salgado"}}]}},"taxonomy_info":{"category":[{"value":415,"label":"Medicamentos e Farm\u00e1cia"}]},"featured_image_src_large":["https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/03\/medicamentos-aprovados.jpg",770,400,false],"author_info":{"display_name":"Simara Laura Salgado","author_link":"https:\/\/prodoctor.net\/blog\/author\/simara-laura\/"},"comment_info":0,"category_info":[{"term_id":415,"name":"Medicamentos e Farm\u00e1cia","slug":"medicamentos-e-farmacia","term_group":0,"term_taxonomy_id":415,"taxonomy":"category","description":"","parent":0,"count":132,"filter":"raw","cat_ID":415,"category_count":132,"category_description":"","cat_name":"Medicamentos e Farm\u00e1cia","category_nicename":"medicamentos-e-farmacia","category_parent":0}],"tag_info":false,"_links":{"self":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/4724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/comments?post=4724"}],"version-history":[{"count":7,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/4724\/revisions"}],"predecessor-version":[{"id":19877,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/4724\/revisions\/19877"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/media\/19814"}],"wp:attachment":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/media?parent=4724"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/categories?post=4724"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/tags?post=4724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}